Who
Stefan Andreas Abele
Chief Technical Ops Officer
Company insider
Files Form 4 as: Chief Technical Ops Officer, Pharvaris.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $4.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 May 2026
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $738K45,000 at $16.40 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $1.7M45,000 at $38.14 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $55K1,400 at $39.24 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —45,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —45,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $738K45,000 at $16.40 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $1.7M45,000 at $38.14 | filing |
| 15 Sep 2026filed 17 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $55K1,400 at $39.24 | filing |
| 15 May 2026filed 19 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $261K8,748 at $29.82 | filing |
| 15 May 2026filed 19 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $261K8,748 at $29.82 | filing |
News
No headline names them, or the companies they trade most, lately.